Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TT A multiplex QIF assay was optimized on tissue ...
Sphere Bio, a leading provider of innovative picodroplet-based microfluidics solutions for functional single-cell analysis and isolation, today announced the launch of the Cyto-Cellect® Human IgG ...
Recently, we’ve watched the biotech industry boom with exciting updates about new projects and technologies. From the unveiling of an innovative hydrogel for neuronal cell culture to advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback